Latest filing published 16 Aug 2011 for ARRAY BIOPHARMA INC, €3,419.
Insider track record
No signal scores available.
Marvin H. Caruthers: trading record in brief
Marvin H. Caruthers discloses dealings in Array Biopharma Inc to SEC (Form 4). In total, 6 filings cover trades dated from 5 May 2010 to 16 August 2011.
Sales make up the whole of the open-market record (2 sales, €7,711). Since January 2011: no purchases and 1 sale on the market.
On 16 August 2011 came the latest disclosure, an open-market sale for €3,419 in Array Biopharma Inc. Filings reach the SEC (Form 4) feed a median of 35 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Marvin H. Caruthers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,300 shares@ US$2.14Common StockSEC:0001127602-11-023701:0
- 88,437 shares0Common StockSEC:0001127602-11-023648:0
- 88,437 shares0Common StockSEC:0001127602-11-023648:1
- 89,326 shares0Common StockSEC:0001127602-10-016878:0
- 89,326 shares0Common StockSEC:0001127602-10-016878:1
- 1,650 shares@ US$3.12Common StockSEC:0001127602-10-016878:2
6 of 6 declarations
